MarketPulse
C

$CELH

12 articles found
5 positive
4 negative
3 neutral
The Motley FoolThe Motley Fool··Neil Patel

Dutch Bros Edges Celsius in Growth Stock Showdown: Operational Momentum Trumps Projections

Dutch Bros' 76.4% net income growth outpaces Celsius' projections, suggesting superior execution and competitive positioning in beverage sector.
BROSCELHacquisitionrevenue growth
The Motley FoolThe Motley Fool··Neil Patel

From 7,330% Surge to 65% Crash: Can Celsius Recover Its Glory?

Celsius stock has plummeted 65% from peaks despite strong fundamentals. High valuation and intense competition pose risks, though growth potential remains.
COSTCELHMNSTvaluationrevenue growth
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

Celsius Stock Slides Amid Costco Competition: A Buying Opportunity or Red Flag?

Celsius stock declines amid Costco competition. Company faces margin pressures while pursuing early-stage international expansion.
COSTCELHcompetitioninternational expansion
The Motley FoolThe Motley Fool··Rick Munarriz

Celsius Stock Faces Headwinds but Analysts See Rebound Potential Ahead

Celsius stock dropped 21% in six days after Costco entered energy drink market, but analysts believe selloff is overdone given strong growth and valuation.
COSTPEPCELHacquisitionstock valuation
The Motley FoolThe Motley Fool··Daniel Sparks

Celsius Stock Drops 49% as Costco Competition Tests Energy Drink Dominance

Celsius Holdings stock plummeted 49% from 52-week highs to $34 amid Costco competition, despite strong Q4 sales of $722M and strategic acquisitions.
COSTCELHgross margin declineacquisition integration
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Celsius Energy Drink Poised for Explosive Growth as PepsiCo Partnership Accelerates

Celsius projects 86% sales growth in 2025 as PepsiCo partnership expands North American distribution and international operations scale into new markets like Spain.
PEPCELHconsumer staplesdistribution expansion
The Motley FoolThe Motley Fool··Jonathan Ponciano

Sotera Health Shares Surge 18% as Major Investor Trims $37M Stake

MIG Capital trims $37.4M Sotera Health stake while maintaining significant position. Company posts record profits, 20-year revenue growth streak amid 18% annual share price gain.
METAMSFTDXCMSHCCELHportfolio rebalancingrevenue growth
The Motley FoolThe Motley Fool··Neil Patel

Celsius Stock: How a $1,000 Investment Became $64,000—But Is the Rally Over?

Celsius stock delivered a stunning 6,300% return over a decade but faces headwinds from competition, expensive 28.4x forward P/E valuation, and modest 10% projected earnings growth, making it unattractive at current levels.
PEPCELHMNSTacquisition strategyvaluation concerns
BenzingaBenzinga··Nabaparna Bhattacharya

Tech Selloff Deepens: Lumentum, Corning Lead Large-Cap Rout in Volatile Week

Large-cap stocks plunged week of March 2-6 as Lumentum, Corning, and MongoDB led declines amid earnings misses, geopolitical tensions, and AI spending concerns.
HLHLpBCCLRKTAG+5earningsguidance
The Motley FoolThe Motley Fool··Travis Hoium

Celsius Seals Transformative Alani Nu Deal, Reaches $2.5B Revenue Milestone

Celsius Holdings hit $2.5B revenue in Q4 2025, driven by Alani Nu acquisition generating $1B+ annually. Core brand growth slowed to 7.5% amid market saturation.
CELHacquisitionrevenue growth
BenzingaBenzinga··Prnewswire

Oral Nicotine Pouches Market Set to Quintuple as Consumer Preferences Shift

Oral nicotine pouch market projected to surge from $5.4B (2024) to $25B+ (2030), prompting major expansion by Celsius, BAT, and Keurig Dr Pepper.
KDPBTITPBCELHconsumer demandportfolio expansion
The Motley FoolThe Motley Fool··Geoffrey Seiler

Celsius Stock Surges on Alani Nu Momentum: Should Investors Buy?

Celsius stock doubled over the past year, driven by Alani Nu acquisition and 117% sales growth. Bank of America upgraded to 'buy,' citing margin expansion potential at reasonable 34x P/E.
BACBACpBBACpEBACpKBACpL+13valuationearnings growth